bioRxiv / medRxiv
open access
CC0 1.0
Effects of Arylsulfatase B and Pembrolizumab in Combination on Progression of Metastatic Melanoma in the B16F10 Syngeneic Mouse Model
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma#471501
- Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients#915540
- Upregulation of <i>RPLP1</i> in PBMCs as a screening biomarker for melanoma#285426
- Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors#67882
- Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma#867718
Record · ID 216662
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive